Grant: Collaborative Health Research Projects (NSERC partnered)
University of British Columbia
$300,000.00
Transcutaneous microsphere vaccine technology
EF 2012-13
Résumé
Common "killed" microbe vaccines such as hepatitis vaccine, must be given repeatedly to be effective. Influenza vaccine must be given yearly. This is costly and inconvenient. In recent work we have shown that vaccines can be incorporated into dissolving spheres that release bursts of vaccine in the skin at timed intervals. We will use this system to obtain the same effect as repeated administration, but with a single administration. The spheres will be delivered into the skin painlessly using new microscopic hollow needles that allow painless administration. We plan to optimize this new method of vaccination by combining the skills of an immunologist, a pharmacy scientist, a mechanical engineer and a clinical vaccinologist. The projected advantages of this new vaccine system are lowered cost, pain free administration, and increased efficacy
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
269670
Name
Dutz Jan P
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Transcutaneous microsphere vaccine technology
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Adjuvant; Biomedical Engineering 1900; Drug Delivery; Human Pharmaceuticals 504; Life Sciences 1200; Life Sciences Research 6400; Microneedles; Microspheres; Nanoparticles; Skin
Abstract
Common "killed" microbe vaccines such as hepatitis vaccine, must be given repeatedly to be effective. Influenza vaccine must be given yearly. This is costly and inconvenient. In recent work we have shown that vaccines can be incorporated into dissolving spheres that release bursts of vaccine in the skin at timed intervals. We will use this system to obtain the same effect as repeated administration, but with a single administration. The spheres will be delivered into the skin painlessly using new microscopic hollow needles that allow painless administration. We plan to optimize this new method of vaccination by combining the skills of an immunologist, a pharmacy scientist, a mechanical engineer and a clinical vaccinologist. The projected advantages of this new vaccine system are lowered cost, pain free administration, and increased efficacy
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dutz, Jan P; Hafeli, Urs O; Kollmann, Tobias R; Stoeber, Boris
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $300,000~ $0~